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The pathogenesis of systemic sclerosis (SSc) is complex and remains incompletely understood, however fibroblasts, monocytes, and endothelial cells (ECs) seem to be key players.
These cells facilitate excessive synthesis of extracellular matrix proteins and deposition of increased amounts of collagen, immune activation, and vascular damage, all of which are known to be important in the development of this illness. [1] Adhesion molecules play multiple roles in angiogenesis. Specific adhesion molecule expression can mediate angiogenesis indirectly by promoting the migration of monocytes. [2] These monocytes are then capable of becoming tissue macrophages and secreting angiogenic factors. Cellular adhesion molecules may have a role in the immunopathogenesis of SSc. [3] We and others have shown that several adhesion molecules are overexpressed in SSc skin. [4, 5] A number of soluble adhesion molecules are also elevated in SSc. [3] JAM-A has been implicated in a variety of physiologic and pathologic processes involving cellular adhesion, tight junction assembly, and leukocyte transmigration. [6, 7] JAM-A facilitates leukocyte adhesion and transmigration through its interaction with lymphocyte function-associated antigen 1 (LFA-1). Recently, JAM-A has been shown to play a role in angiogenesis. [8] As SSc is characterized by both inflammatory cell infiltration and vasculopathy, we hypothesized that JAM-A may play a role in its pathogenesis. Here we demonstrate aberrant expression of JAM-A in SSc skin and sJAM-A in SSc serum. Moreover, we show a novel role for JAM-A in mediating myeloid cell adhesion to SSc skin.
Materials and methods
Patients and controls. Skin punch biopsies and peripheral blood samples were obtained from subjects with SSc (all with diffuse disease) and control subjects. All SSc patients fulfilled the American College of Rheumatology criteria for SSc and also met the criteria for diffuse SSc. [1, 9] Biopsies were taken with full informed consent, and this study was approved by the Institutional Review Board.
Immunohistology. We performed immunohistologic staining on cryosections from SSc and normal skin, as described previously. [10] Goat anti-human JAM-A antibody (R&D Systems, Minneapolis, MN) was used as a primary antibody. The slides were read by a pathologist under blinded conditions. For JAM-A staining, the percentage of positive cells was calculated semiquantitatively as stained cells in proportion to all cells of a distinctive subset. We also used a similar method with an anti-von Willebrand factor antibody to identify endothelial cells. Blood vessels were scored using a scale of: 0=avascular; 1=slight decrease; 2=normal; 3=slight increase; 4=marked increase.
Immunofluorescence. We performed immunofluorescence on cryosections from SSc and normal skin. Sections were fixed with 4% formalin and blocked with 20% fetal bovine serum and 5% donkey serum. Goat anti-human JAM-A antibody (R&D Systems) and mouse antihuman Von Willebrand factor (vWF) (Dako, Denmark) were used as primary antibodies.
Fluorescent conjugated secondary antibodies were purchased from Molecular Probes (Eugene, OR). 4',6-diamidino-2-phenylindole (DAPI) was used to stain cell nuclei. Images were taken at 400x.
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Cell lysis and western blotting. NL and SSc dermal fibroblast cell lines were established as described previously. [11] Cell lysis and western blotting were performed as described. [10] Membranes were probed with anti-human JAM-A antibody (R&D Systems). Densitometric analysis of the bands was performed using UN-SCAN-IT software, version 5.1 (Silk Scientific).
Cell surface ELISA. Cell surface ELISAs were performed as previously described. [10] Dermal fibroblasts were plated in 96-well plates, stimulated with tumor necrosis factor-alpha (TNF-α), or interleukin-1β (IL-1β), or interferon-γ (IFN-γ) (all 25 ng/ml, R&D Systems) or incubated in serum free RPMI for 24 hours. The fibroblasts were incubated with anti-human JAM-A antibody (R&D Systems) or goat IgG.
Human dermal microvascular endothelial cell (HMVEC) cell culture. HMVECs were obtained from Lonza (Basel, Switzerland) and cultured using EBM complete media (Lonza).
The cells were serum starved overnight and then stimulated with either TNF-α or IL-1β.
Supernatants were collected and concentrated using Amicon ultra filters (Millipore). 
Stamper-Woodruff adhesion assay.
In situ assays were performed as previously described. Statistical analysis. Student's t-tests were performed, and P values less than 0.05 were considered significant. All values presented were the mean ± standard error of the mean (SEM).
Results
Patient characteristics. The SSc group consisted of 18 females and 2 males (52.5 ± 1.8 years), while the NL control group consisted of 7 males and 3 females (51.2 ± 4.4 years). The mean disease duration of the SSc group was 3.7 ± 0.8 years. Punch biopsies were taken from clinically less involved proximal arm skin (mean skin score 1.2 ± 0.2) and involved distal forearm skin (2.0 ± 0.2). The proximal biopsy site was far away from the leading edge of the distal area.
SSc distal arm skin had significantly fewer blood vessels compared to NL skin. Our work confirmed that in our patient population SSc distal arm skin has significantly fewer blood vessels (blood vessel score=1.7) compared to NL skin (blood vessel score=2.0, p<0.05) (figure 1). [12] In addition, we found that SSc proximal arm skin (blood vessel scale score=1.9) had a blood vessel score between that of SSc distal skin and NL skin. compared to NL skin (mean of 98%, p<0.05, figure 2J ). In contrast, SSc dermal perivascular macrophages expressed increased levels of JAM-A (12% in distal skin and 18% in proximal skin) compared to NL skin (mean of 4%, both p<0.05) (data not shown). Similarly, SSc subepidermal macrophages expressed increased levels of JAM-A (mean of 8% in distal skin and mean of 8% in proximal skin) compared to NL skin (mean of 3%, both p<0.05) (data not shown).
JAM-A is abnormally expressed in SSc skin. JAM-A expression in normal and

JAM-A was more highly expressed on SSc dermal fibroblasts vs. NL dermal fibroblasts.
JAM-A was more highly expressed on dermal SSc compared to NL fibroblasts ( figure 3A ).
Western blotting resulted in similar results ( figure 3B) . However, the expression of JAM-A on either SSc or NL dermal fibroblasts was not inducible by TNF-α, IFN-γ, or IL-1β (data not shown). Fig 4A) . n=the number of patients. sJAM-A is found in the culture supernatants of HMVECs (Fig 4B) , and its expression is increased with stimulation by TNF-α.n=the number of replicates. 
